National trends and outcomes for extra-corporeal membrane oxygenation use in high-risk pulmonary embolism.

Vascular Medicine (London, England) Pub Date : 2019-06-01 Epub Date: 2019-03-05 DOI:10.1177/1358863X18824650
Ayman Elbadawi, Amgad Mentias, Islam Y Elgendy, Ahmed H Mohamed, Mohammed Hz Syed, Gbolahan O Ogunbayo, Odunayo Olorunfemi, Igor Gosev, Sunil Prasad, Scott J Cameron
{"title":"National trends and outcomes for extra-corporeal membrane oxygenation use in high-risk pulmonary embolism.","authors":"Ayman Elbadawi,&nbsp;Amgad Mentias,&nbsp;Islam Y Elgendy,&nbsp;Ahmed H Mohamed,&nbsp;Mohammed Hz Syed,&nbsp;Gbolahan O Ogunbayo,&nbsp;Odunayo Olorunfemi,&nbsp;Igor Gosev,&nbsp;Sunil Prasad,&nbsp;Scott J Cameron","doi":"10.1177/1358863X18824650","DOIUrl":null,"url":null,"abstract":"<p><p>Little is known about the temporal trends and outcomes for extra-corporeal membrane oxygenation (ECMO) in patients with high-risk pulmonary embolism (PE) in the United States. We queried the National Inpatient Sample (NIS) database from 2005 to 2013 to identify patients admitted with high-risk PE. Our objective was to determine trends for ECMO use in patients with high-risk PE. We also assessed in-hospital outcomes among patients with high-risk PE receiving ECMO. We evaluated 77,809 hospitalizations for high-risk PE. There was an upward trend in the utilization of ECMO from 0.07% in 2005 to 1.1% in 2013 ( p = 0.015). ECMO was utilized more in urban teaching hospitals and large hospitals. ECMO use was associated with lower mortality in patients with massive PE ( p < 0.001). In-hospital mortality for patients receiving ECMO was 61.6%, with no change over the observational period ( p = 0.68). Our investigation revealed several independent predictors of increased mortality in patients with high-risk PE using ECMO as hemodynamic support, including: age, female sex, obesity, congestive heart failure, and chronic pulmonary disease. ECMO, therefore, as a rescue strategy or bridge to definitive treatment, may be effective in the management of high-risk PE when selecting patients with favorable clinical characteristics.</p>","PeriodicalId":151049,"journal":{"name":"Vascular Medicine (London, England)","volume":" ","pages":"230-233"},"PeriodicalIF":0.0000,"publicationDate":"2019-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1358863X18824650","citationCount":"32","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vascular Medicine (London, England)","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/1358863X18824650","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/3/5 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 32

Abstract

Little is known about the temporal trends and outcomes for extra-corporeal membrane oxygenation (ECMO) in patients with high-risk pulmonary embolism (PE) in the United States. We queried the National Inpatient Sample (NIS) database from 2005 to 2013 to identify patients admitted with high-risk PE. Our objective was to determine trends for ECMO use in patients with high-risk PE. We also assessed in-hospital outcomes among patients with high-risk PE receiving ECMO. We evaluated 77,809 hospitalizations for high-risk PE. There was an upward trend in the utilization of ECMO from 0.07% in 2005 to 1.1% in 2013 ( p = 0.015). ECMO was utilized more in urban teaching hospitals and large hospitals. ECMO use was associated with lower mortality in patients with massive PE ( p < 0.001). In-hospital mortality for patients receiving ECMO was 61.6%, with no change over the observational period ( p = 0.68). Our investigation revealed several independent predictors of increased mortality in patients with high-risk PE using ECMO as hemodynamic support, including: age, female sex, obesity, congestive heart failure, and chronic pulmonary disease. ECMO, therefore, as a rescue strategy or bridge to definitive treatment, may be effective in the management of high-risk PE when selecting patients with favorable clinical characteristics.

Abstract Image

Abstract Image

体外膜氧合用于高危肺栓塞的国家趋势和结果。
在美国,对于高危肺栓塞(PE)患者体外膜氧合(ECMO)的时间趋势和结果知之甚少。我们查询了2005年至2013年的国家住院患者样本(NIS)数据库,以确定入院的高危PE患者。我们的目的是确定高危PE患者使用ECMO的趋势。我们还评估了接受ECMO的高风险PE患者的住院结果。我们评估了77,809例高风险PE住院病例。ECMO使用率由2005年的0.07%上升至2013年的1.1% (p = 0.015)。ECMO在城市教学医院和大型医院应用较多。使用ECMO与大量PE患者较低的死亡率相关(p < 0.001)。接受ECMO患者的住院死亡率为61.6%,在观察期内无变化(p = 0.68)。我们的研究揭示了使用ECMO作为血流动力学支持的高危PE患者死亡率增加的几个独立预测因素,包括:年龄、女性、肥胖、充血性心力衰竭和慢性肺部疾病。因此,当选择具有良好临床特征的患者时,ECMO作为一种抢救策略或最终治疗的桥梁,可能对高危PE的管理有效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信